References
- Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, Diéras V, Mathiot C, Mignot L, Thiery JP, Sastre-Garau X, Pierga JY. (2008) Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. Ann Oncol. (Mar 2008) 19(3):496-500. https://www.ncbi.nlm.nih.gov/pubmed/18187488
- Blumenschein GR, DiStefano A, Caderao J, Fristenberg B, Adams J, Schweichler LH, Drinkard L. (1997) Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy. Clin Cancer Res. (dec. 1997) 3(12 Pt 2):2633-7. https://www.ncbi.nlm.nih.gov/pubmed/10068266
- Chung CT, Carlson RW. (2003) Goals and Objectives in the Management of Metastatic Breast Cancer. The Oncologist, (Dec. 2003) Vol. 8, No. 6, 514–520. https://www.ncbi.nlm.nih.gov/pubmed/14657529
- Coleman RE, Rubens RD, Fogelman I. (1988) Reappraisal of the baseline bone scan in breast cancer. J Nucl Med. 1988 Jun;29(6):1045-9. https://www.ncbi.nlm.nih.gov/pubmed/3373314
- Dubois JB, Saumon-Reme M, Gary-Bobo J, Pourquier H, Pujol H. (1990) Tumorectomy and radiation therapy in early breast cancer: a report on 392 patients. Radiology. (Jun 1990) 175(3):867-71. https://www.ncbi.nlm.nih.gov/pubmed/2343138
- Gamel JW, Vogel RL, Vlagussa P, Bonadonaa G. (1994) Parametric survival analysis of adjuvant therapy for stage II breast cancer. Cancer (Nov. 1994) Volume 74, Issue 9, pages 2483–2490. https://www.ncbi.nlm.nih.gov/pubmed/7923004
- Honkoop AH, Wagstaff J, Pinedo HM. (1998) Management of Stage III Breast Cancer. Oncology (1998);55:218-227 https://www.ncbi.nlm.nih.gov/pubmed/9560054
- Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D. (et al). (1988) Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer (1988);62(12):2507-16. https://www.ncbi.nlm.nih.gov/pubmed/3056604
- Klefstrom P, Grohn P, Heinonen E, Holsti L, Holsti P. (1987) Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole. Cancer (1987);60(5):936-42 http://onlinelibrary.wiley.com/doi/10.1002/1097-0142(19870901)60:5%3C936::AID-CNCR2820600504%3E3.0.CO;2-P/abstract
- Rizzo M, Reisman N, Gabram SG, Bumpers HL, Okoli J, Brawley, OW, Lund, M. (2007) Differences in treatment in stage III breast cancer in African American women. Journal of Clinical Oncology, (2007) ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 25, No 18S (June 20 Supplement), 2007: 504 https://www.ncbi.nlm.nih.gov/pubmed/19466698
- Stephen FO. (1990) Intraarterial induction chemotherapy in locally advanced stage III breast cancer. Cancer (Aug. 1990) Volume 66, Issue 4, pages 645–650. https://www.ncbi.nlm.nih.gov/pubmed/2386893
- Stewart JF, King RJB, Winter PJ, Tong D, Hayward JL, Rubens RD. (1982) Oestrogen receptors, clinical features and prognosis in stage III breast cancer. European Journal of Cancer and Clinical Oncology: Volume 18, Issue 12, Pages 1315-1320 https://www.ncbi.nlm.nih.gov/pubmed/6891930
- Wolff AC, Davidson NE. (2000) Primary systemic therapy in operable breast cancer. J Clin Oncol (2000);18(7):1558-69 https://www.ncbi.nlm.nih.gov/pubmed/10735905
- Yang SH, Yang KH, Li YP, Zhang YC, He XD, Song AL, Tian JH, Jiang L, Bai ZG, He LF, Liu YL, Ma B. (2008) Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials. Ann Oncol.(Jun 2008) 19(6):1039-44. https://www.ncbi.nlm.nih.gov/pubmed/18187486
- Yeatman TJ. (1995) The natural history of locally advanced primary breast carcinoma and metastatic disease. Surg Oncol Clin N Am (1995);4:569–589. https://www.ncbi.nlm.nih.gov/pubmed/8535899
Back to Stages and Progression of Breast Cancer